Patients | ULC therapy (n=113) | RFVE therapy (n=263) | p-value | |
---|---|---|---|---|
Sex (M/F) | 72/41 (64%/36%) | 157/106 (60%/40%) | 0.5 a | |
Age (years ± SD) | 65.4 ± 12.5 | 60.2 ± 14.3 | <0.001 b | |
Ischemic/hemorrhagic stroke | 82/31 (73%/27%) | 188/75 (71%/29%) | 0.6 a | |
Affected hemisphere (R/L) | 58/55 (51%/49%) | 126/137 (48%/51%) | 0.7 a | |
Upper limb motor impairment | Severe (F-M UE≤20) | 19 (17%) | 35 (13%) | 0.6 a |
Moderate (21≤F-M UE≤40) | 29 (26%) | 72 (27%) | 0.9 a | |
Mild (F-M UE>40) | 65 (57%) | 156 (59%) | 0.8 a | |
Stroke to Rehabilitation Interval | ≤ 3 months | 32 (28%) | 68 (26%) | 0.7 a |
3 < months < 12 | 57 (50%) | 113 (43%) | 0.2 a | |
≥ 12 months | 24 (21%) | 82 (31%) | 0.1 a |